Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
General Healthcare
Filter
Journals
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Metformin: Hidden Brain Pathway to Lower Blood Sugar Revealed
March 2026
Scientists have discovered a previously unknown neural pathway behind the antidiabetic effects of metformin, a standard first-line treatment for Type 2 diabetes.
Read more
22 Sep 2014
European Commission Grants Marketing Authorisation for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia and Follicular Lymphoma
Foster City, CA, 19 September 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted marketing…
9 Jul 2014
Calls for UK to Pilot New Reimbursement Models for Antibiotics
Pharmaceutical industry leaders are calling for an alternative reimbursement model for antibiotics in the UK sooner rather than later in order to…
4 Jul 2014
Drug Shows Promise for Effectively Treating Metabolic Syndrome
University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome…
11 Jun 2014
National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.
RESEARCH TRIANGLE PARK, N.C., June 10, 2014 /PRNewswire/ — ViiV Healthcare today announced new survey data that provide important insights that may…
1 Jun 2014
Walking Month in May 2014
As you may have noticed across our social platforms this month, we have been spreading the awareness of National Walking Month 2014.
26 May 2014
Scientists Discover Potential New Target for Cancer Immunotherapy
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and…
13 May 2014
Scientists Find New Way to Mobilize Immune System against Viruses
University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop…
9 May 2014
New Method Sneaks Drugs into Cancer Cells before Triggering Release
Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before…
Loading posts...
« Previous
1
…
55
56
57
58
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View